Miller Anestesia

957 / 2894

7. Steiner I, Argov Z, Cahan C, Abramsky O: Guillain-
Barré syndrome after epidural anesthesia: Direct
nerve root damage may trigger disease. Neurology
35:1473-1475, 1985.
8. Rudnik-Schneborn S, De Visser M, Zerres K: Spinal
muscular atrophies. In EngelA,Franzini-Armstrong
C (eds): Myology. NewYork, McGraw-Hill, 2004, pp
1845-1864.
9. Cruse R: Hereditary primary motor sensory neuro-
pathies, including Charcot-Marie-Tooth disease.
April 29,2007.Available from:
Accessed July 2007.
10. Ginz HF, Ummenhofer WC, Erb T, Urwyler A: [The
hereditarymotor-sensoryneuropathyCharcot-Marie-
Tooth disease: Anesthesiologic management—case
report with literature review.] Anaesthesist 50:767-
771, 2001.
11. Gratarola A, Mameli MC, Pelosi G: Total intrave-
nous anaesthesia in Charcot-Marie-Tooth disease.
Case report. Minerva Anestesiol 64:357-360, 1998.
12. Sugino S, Yamazaki Y, Nawa Y, et al: [Anesthetic
management of a patient with Charcot-Marie-
Tooth disease using propofol and nitrous oxide.]
Masui 51:1016-1019, 2002.
13. Baur CP, Schara U, Schlecht R, et al: [Anesthesia in
neuromuscular disorders. Part 2: Specific disor-
ders.] Anasthesiol Intensivmed Notfallmed Sch-
merzther 37:125-137, 2002.
14. Antognini JF:Anaesthesia for Charcot-Marie-Tooth
disease: A review of 86 cases. Can J Anaesth 39:398-
400, 1992.
15. Baranov D, Kelton T, McClung H, et al: Neurologi-
cal diseases. In Fleisher L (ed): Anesthesia and
Uncommon Diseases. Philadelphia, Saunders
Elsevier, 2006.
16. Pogson D, Telfer J, Wimbush S: Prolonged vecuro-
nium neuromuscular blockade associated with
Charcot Marie Tooth neuropathy. Br J Anaesth
85:914-917, 2000.
17. Naguib M,Samarkandi AH: Response to atracurium
and mivacurium in a patient with Charcot-Marie-
Tooth disease. Can J Anaesth 45:56-59, 1998.
18. Schmitt HJ, Munster T: Mivacurium-induced neu-
romuscular block in adult patients suffering from
Charcot-Marie-Tooth disease. Can J Anaesth
53:984-988, 2006.
19. Reah G, Lyons GR, Wilson RC: Anaesthesia for
caesarean section in a patient with Charcot-Marie-
Tooth disease. Anaesthesia 53:586-588, 1998.
20. Scull T, Weeks S: Epidural analgesia for labour in a
patient with Charcot-Marie-Tooth disease. Can J
Anaesth 43:1150-1152, 1996.
21. Sugai K, Sugai Y: [Epidural anesthesia for a patient
with Charcot-Marie-Tooth disease,bronchial asthma
and hypothyroidism.] Masui 38:688-691, 1989.
22. Tanaka S,Tsuchida H,Namiki A: [Epidural anesthe-
sia for a patient with Charcot-Marie-Tooth disease,
mitral valve prolapse syndrome and second degree
AV block.] Masui 43:931-933, 1994.
23. Schmitt HJ, Muenster T, Schmidt J: Central neural
blockade in Charcot-Marie-Tooth disease. Can J
Anaesth 51:1049-1050, 2004.
24. Dubowitz V: Muscle Disorders in Childhood, 2nd
ed. Philadelphia, WB Saunders, 1995, pp 34-132.
25. Dalakas M, Palace J, Rose M: The muscular dystro-
phies. In Barnes P,Hilton-Jones D (eds): Myopathies
in Clinical Practice. London, Martin Dunitz, 2003,
pp 59-83.
26. Do T: Muscular Dystrophy. Available from
Accessed March 30, 2007.
27. Emery A: Population frequencies of inherited
neuromuscular diseases—a world survey. Neuro-
muscul Disord 1:19-29, 1991.
28. Sano M, Saito F,Yamamoto K, et al: Duchenne mus-
cular dystrophy in a female with 45,X/46,XX chro-
mosome constitution. Jinrui Idengaku Zasshi
32:257-262, 1987.
29. Urban M, Lahlou S: Muscle diseases. In Fleisher L
(ed): Anesthesia and Uncommon Diseases. Phila-
delphia, Saunders Elsevier, 2006, pp 303-325.
30. Hoffman E: Dystroph: The protein product of the
Duchenne muscular dystrophy locus. Cell 51:
919-928, 1987.
31. Leibowitz D, Dubowitz V: Intellect and behaviour
in Duchenne muscular dystrophy. Dev Med Child
Neurol 23:577-590, 1981.
32. Finsterer J, Stollberger C: The heart in human dys-
trophinopathies. Cardiology 99:1-19, 2003.
33. Perloff JK, Henze E, Schelbert HR: Alterations in
regional myocardial metabolism, perfusion, and
wall motion in Duchenne muscular dystrophy
studied by radionuclide imaging. Circulation 69:33-
42, 1984.
34. Morris P: Duchenne muscular dystrophy: A cha-
llenge for the anaesthetist. Paediatr Anaesth 7:1-4,
1997.
35. Hahn A, Bach JR, Delaubier A, et al: Clinical impli-
cations of maximal respiratory pressure determina-
tions for individuals with Duchenne muscular
dystrophy. Arch Phys Med Rehabil 78:1-6, 1997.
36. Ames WA, Hayes JA, Crawford MW: The role of
corticosteroids in Duchenne muscular dystrophy:A
review for the anesthetist. Paediatr Anaesth 15:3-8,
2005.
37. Kawaai H, Tanaka K,Yamazaki S: Continuous infu-
sion propofol general anesthesia for dental
treatment in patients with progressive muscular
dystrophy. Anesth Prog 52:12-16, 2005.
38. Molyneux MK: Anaesthetic management during
labour of a manifesting carrier of Duchenne muscu-
lar dystrophy. Int J Obstet Anesth 14:58-61, 2005.
39. Angermann C, Spes C, Pongratz D: [Cardiac mani-
festation of progressive muscular dystrophy of the
Duchenne type.] Z Kardiol 75:542-551, 1986.
40. Smith CL, Bush GH: Anaesthesia and progressive
muscular dystrophy. Br J Anaesth 57:1113-1118,
1985.
41. Webster R: Respiratory function as a measure of
muscle strength in young boys with Duchenne
muscular dystrophy. In Neurology. University of
N.S.W., School of Women and Children’s Health,
2003.
42. Stevens RD: Neuromuscular disorders and anesthe-
sia. Curr Opin Anaesthesiol 14:693-698, 2001.
43. Breucking E, Reimnitz P, Schara U, Mortier W:
[Anesthetic complications. The incidence of severe
anesthetic complications in patients and families
with progressive muscular dystrophy of the
Duchenne and Becker types.] Anaesthesist 49:187-
195, 2000.
44. Benson ER, Thompson JD, Smith BG, Banta JV:
Results and morbidity in a consecutive series of
patients undergoing spinal fusion for neuromuscu-
lar scoliosis. Spine 23:2308-2317, discussion, 2318
1998.
45. Miller F, Moseley CF, Koreska J: Spinal fusion in
Duchenne muscular dystrophy. Dev Med Child
Neurol 34:775-786, 1992.
46. Jenkins JG, Bohn D, Edmonds JF, et al: Evaluation
of pulmonary function in muscular dystrophy
patients requiring spinal surgery. Crit Care Med
10:645-649, 1982.
47. Stoelting R, Dierdorf S. Anesthesia and Co-existing
Disease. Philadelphia, Churchill Livingstone, 2002,
pp 505-549.
48. Brandom B, Apuya J. Epidemiological challenges in
malignant hyperthermia. Available from
Accessed July 2007.
49. Farell P: Anesthesia-induced rhabdomyolysis
causing cardiac arrest: Case report and review of
anesthesia and the dystrophinopathies. Anesth
Intensive Care 22:597-601, 1994.
50. Schummer W, Schummer C: Acute heart failure
during spinal surgery in a boy with Duchenne mus-
cular dystrophy. Br J Anaesth 92:149, author reply
149-150, 2004.
51. Ririe DG, Shapiro F, Sethna NF: The response of
patients with Duchenne’s muscular dystrophy to
neuromuscular blockade with vecuronium. Anes-
thesiology 88:351-354, 1998.
52. Yemen TA, McClain C: Muscular dystrophy, anes-
thesia and the safety of inhalational agents revisited;
again. Paediatr Anaesth 16:105-108, 2006.
53. Fairfield MC: Increased propofol requirements in a
child with Duchenne muscular dystrophy. Anaes-
thesia 48:1013, 1993.
54. Murat I, Esteve KC, Montay G, et al: Pharmacoki-
netics and cardiovascular effects of bupivacaine
during epidural anesthesia in children with
Duchenne muscular dystrophy. Anesthesiology
67:249-252, 1987.
55. Kirschner J, Bonnemann CG: The congenital and
limb-girdle muscular dystrophies: Sharpening the
focus, blurring the boundaries.Arch Neurol 61:189-
199, 2004.
56. Moro C, Dangelser G, Veyckemans F: [Anesthetic
management of a child with delta sarcoglycanopa-
thy.] Ann Fr Anesth Reanim 26:359-362, 2007.
57. Egi M, Tokioka H, Chikai T, et al: [Propofol anes-
thesia for a patient with progressive muscular dys-
trophy.] Masui 51:196-198, 2002.
58. Pash MP, Balaton J, Eagle C: Anaesthetic manage-
ment of a parturient with severe muscular dystro-
phy, lumbar lordosis and a difficult airway. Can J
Anaesth 43:959-963, 1996.
59. Myotonic Dystrophy, November 2006. Available
from
Accessed July 2007.
60. Bird T. Myotonic Dystrophy Type 1, 2005. Available
from
Accessed July 2007.
61. Krivickas LS, Ansved T, Suh D, Frontera WR: Con-
tractile properties of single muscle fibers in myoto-
nic dystrophy. Muscle Nerve 23:529-537, 2000.
62. Dalton J, Ranum L, Day J: Myotonic dystrophy type
2. In GeneReviews 2007. Available at
.
63. Mathieu J, Allard P, Gobeil M, et al: Anesthetic and
surgical complications in 219 cases of myotonic
dystrophy. Neurology 49:1646-1650, 1997.
64. Catena V, Del Monte DD, Rubini A, et al: Anesthesia
and myotonic dystrophy (Steinert’s syndrome). The
role of total intravenous anesthesia with propofol,
cisatracurium and remifentanyl. Case report.
Minerva Anestesiol 73:475-479, 2007.
65. Lehmann-Horn F, Reinhardt R, Jurkat-Rott K:
Altered excitability of the cell membrane. In Engel
A,Franzini-Armstrong C (eds): Myology.NewYork,
McGraw-Hill, 2004, pp 1257-1300.
66. Farbu E, Softeland E, Bindoff LA: Anaesthetic com-
plications associated with myotonia congenita: Case
study and comparison with other myotonic disor-
ders. Acta Anaesthesiol Scand 47:630-634, 2003.
67. Newberg LA, Lambert EH, Gronert GA: Failure to
induce malignant hyperthermia in myotonic goats.
Br J Anaesth 55:57-60, 1983.
68. Beck CL, Fahlke C, George AL Jr: Molecular basis
for decreased muscle chloride conductance in the
myotonic goat. Proc Natl Acad Sci USA 93:11248-
11252, 1996.
Trastornos neuromusculares e hipertermia maligna 957 27
Sección
III
Control de la anestesia
© ELSEVIER. Fotocopiar sin autorización es un delito